UTHR250117P460000
- 0.00
- 0.000.00%
United Therapeutics Newsroom
How Is The Market Feeling About United Therapeutics?
Insider Sale: PRESIDENT AND COO of $UTHR (UTHR) Sells 500 Shares
United Therapeutics(UTHR.US) Officer Sells US$3.57 Million in Common Stock
United Therapeutics' (NASDAQ:UTHR) Investors Will Be Pleased With Their Enviable 316% Return Over the Last Five Years
We Ran A Stock Scan For Earnings Growth And United Therapeutics (NASDAQ:UTHR) Passed With Ease
United Therapeutics Corporation (UTHR): Among the Cheap Healthcare Stocks to Buy Heading Into 2025
United Therapeutics(UTHR.US) Officer Sells US$3.62 Million in Common Stock
Here Are Updates on United Therapeutics Corp. (UTHR)
United Therapeutics(UTHR.US) Director Sells US$9.78 Million in Common Stock
Express News | Form 144 | United Therapeutics(UTHR.US) Director Proposes to Sell 9.78 Million in Common Stocks
United Therapeutics(UTHR.US) Officer Sells US$3.7 Million in Common Stock
United Therapeutics Announces Successful World's First UKidney Transplant
Express News | Form 144 | United Therapeutics(UTHR.US) Officer Proposes to Sell 14.47 Million in Common Stocks
$1000 Invested In United Therapeutics 20 Years Ago Would Be Worth This Much Today
United Therapeutics(UTHR.US) Officer Sells US$3.68 Million in Common Stock
United Therapeutics (NASDAQ:UTHR) Has A Rock Solid Balance Sheet
United Therapeutics(UTHR.US) Officer Sells US$3.71 Million in Common Stock
The 3.8% Return This Week Takes United Therapeutics' (NASDAQ:UTHR) Shareholders Five-year Gains to 314%
Insider Sale: PRESIDENT AND COO of $UTHR (UTHR) Sells 100 Shares
United Therapeutics(UTHR.US) Officer Sells US$3.73 Million in Common Stock